Clinical benefit of the gedatolisib regimens was consistent across patient subgroups Hyperglycemia was reported in only 9.2% of patients treated with gedatolisib + palbociclib + fulvestrant ...
Medpage Today on MSN
Another 'Practice-Changing' Study in High-Risk Bladder Cancer
BERLIN -- Adding durvalumab (Imfinzi) to bacillus Calmette-Guérin (BCG) induction and maintenance therapy significantly ...
MedPage Today on MSN
How Do GLP-1 Drugs Stack Up for Cardiorenal Benefits in Diabetes?
"As of now, semaglutide is FDA-indicated for slowing chronic kidney disease progression, [but] our results suggest that ...
A 29-year-old man undergoes a total proctocolectomy with end-to-end ileostomy after 2 years of surveillance for ulcerative colitis.
Running faster isn’t just for more experienced athletes. Here’s exactly what you need to know about adding speed workouts to ...
There's a lot more clarity about the Seattle Mariners' pitching after Game 1 of the ALCS. Details on that plus a live BP for ...
Giredestrant plus everolimus reduced the risk of disease progression or death by 44% and 62% in ITT and ESR1-mutated ...
The article 🌱 Patch AM: Progressions - 2nd Year Lessons and 10 more events appeared first on Shorewood Patch. Hello ...
The five-year invasive disease-free survival (iDFS) rates were 85.5% in the Kisqali plus ET arm versus 81.0% in the ET alone arm, representing a clinically meaningful 4.5% improvement 1. These ...
4don MSN
Vikings welcome McCarthy back to practice but won't commit yet to starting QB this week vs. Eagles
The Minnesota Vikings returned from their bye week not yet ready to rule J.J. McCarthy in or out at quarterback after missing ...
The Bills head to their bye week on a two-game losing streak after a humbling 24-14 loss in Atlanta. Here are Sal Maiorana's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results